Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study

Journal of Pharmaceutical Health Care and Sciences
Tomoyuki SaitoHiroyuki Daida

Abstract

Patients with diabetes are at higher risk of developing polypharmacy because of the high frequency of comorbidities. There have been several reports on the hypoglycemic risk of the combination of hypoglycemic agents and other medications. This study aimed to investigate the hypoglycemic risk of drug-drug interaction between sitagliptin and other oral hypoglycemic agents or antihypertensive agents in Japanese patients with type 2 diabetes. From January 2010 to March 2012, a total of 3247 patients were recruited and evaluated at outpatient clinics at Juntendo University Hospital, other satellite hospitals, and private clinics. This study was a sub-analysis of the Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project. Participants were limited to those treated with oral hypoglycemic agents, excluding insulin users, to investigate the association of the first hypoglycemic events with oral hypoglycemic agents or other medications within 6 months after starting sitagliptin. The factors related to the first hypoglycemic event were analyzed using Cox regression analysis. In total, 2956 patients with a mean age of 65.1 ± 11.3 years were included. A total of 46 hypoglycemic events (1.6%) were observed. One patient had s...Continue Reading

References

Mar 1, 1985·The Journal of Clinical Investigation·M ModanZ Fuchs
May 1, 1974·The Journal of Clinical Investigation·J E GerichP H Forsham
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J C ChanJ A Critchley
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Jan 14, 2010·Current Medical Research and Opinion·Vivian A Fonseca
Feb 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Ghassan Jarred, R Lee Kennedy
Feb 26, 2013·The European Journal of General Practice·Conor TeljeurTom O'Dowd
Oct 19, 2010·Journal of Diabetes Investigation·Yutaka SeinoKohjiro Ueki
Jun 5, 2014·Clinical Cardiology·Vani P SanonRobert Chilton
Feb 24, 2015·Journal of Clinical Medicine Research·Hirotoshi OhmuraUNKNOWN SPIRITS-J Study Investigators
Jan 18, 2017·Diabetes, Obesity & Metabolism·Tetsuro TsujimotoHiroshi Kajio
Jun 1, 2017·Hypertension·Edoardo Casiglia, Valérie Tikhonoff
Jun 1, 2017·Hypertension·Tetsuro TsujimotoHiroshi Kajio
Jun 9, 2017·European Journal of Human Genetics : EJHG·James R StaleyJoanna M M Howson
Mar 3, 2018·Diabetes Research and Clinical Practice·N H ChoB Malanda
Mar 3, 2018·Journal of Diabetes Investigation·Mitsuyoshi NambaUNKNOWN Japan Diabetes Society (JDS) Committee for Surveys on Severe Hypoglycemia
Mar 28, 2018·Journal of Diabetes Investigation·Masakazu HanedaEiichi Araki
Mar 1, 2019·Endocrinology, Diabetes & Metabolism·M Angelyn BethelUNKNOWN TECOS Study Group
May 14, 2019·Journal of Geriatric Cardiology : JGC·Aaqib H MalikRamzi El Accaoui

❮ Previous
Next ❯

Citations

May 16, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Atsushi Tanaka, Koichi Node

❮ Previous
Next ❯

Software Mentioned

SPIRITS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Nederlands tijdschrift voor geneeskunde
D W Erkelens
Nihon rinsho. Japanese journal of clinical medicine
Manabu Kondo, Yukio Tanizawa
The Medical Letter on Drugs and Therapeutics
© 2022 Meta ULC. All rights reserved